Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood marker may prevent fluid overload in kids after heart surgery

NCT ID NCT07255469

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at a blood test that may help doctors decide which children need extra fluids after heart surgery. Giving fluids when not needed can be harmful. The researchers will check if a certain blood marker can predict which children will benefit from fluids. About 110 children in intensive care will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 110 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient hospitalized in an intensive care unit after cardiac surgery with a prescription of a 10ml/kg fluid expansion by the physician in charge

Ages

0 days to 15 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age less than or equal to 15 years old * Hospitalization in a pediatric intensive care unit after cardiac surgery * Prescription by the attending physician of a fluid expansion of 10ml/kg * Prescription of arterial and venous blood gas before and after the volume expansion to help manage acute circulatory failure * Patient implanted with a functioning arterial line * Patient implanted with a functioning central venous line in the superior vena cava territory Exclusion Criteria: * Patient less than 37 weeks' corrected gestational age * Hemodynamic instability making the delay necessary for any test dangerous * Supine position contraindicated or deleterious * Impairment of echocardiographic acoustic window or restless patient making ultrasonography impossible * Opposition to participate expressed by the patient or by a parent or legal guardian

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Circulatory failure / shock state are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Shock

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hôpital Cardiologique Haut Lévêque - CHU de Bordeaux

    RECRUITING

    Pessac, France, 33604, France

  • Hôpital Felix Guyon - CHU de la Réunion

    RECRUITING

    Saint-Denis, La Réunion, 97400, France

  • Hôpital Jeanne de Flandre - CHU de Lille

    RECRUITING

    Lille, France, 59000, France

  • Hôpital Louis Pradel - Hospices Civils de Lyon

    RECRUITING

    Bron, France, 69500, France

  • Hôpital Necker-Enfants Malades - Assistance Publique - Hôpitaux de Paris

    RECRUITING

    Paris, France, 75015, France

  • Hôpital de la Timone - Assistance Publique - Hôpitaux de Marseille

    NOT_YET_RECRUITING

    Marseille, France, 13385, France

  • Hôpital des enfants - CHU de Toulouse

    NOT_YET_RECRUITING

    Toulouse, France, 31300, France

  • Hôpital mère-enfant - CHU de Nantes

    RECRUITING

    Nantes, France, 44093, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.